Jazz Pharmaceuticals
JAZZ
JAZZ
459 hedge funds and large institutions have $8.8B invested in Jazz Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 150 increasing their positions, 145 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
459
Holders Change
+7
Holders Change %
+1.55%
% of All Funds
7.26%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.14%
New
75
Increased
150
Reduced
145
Closed
59
Calls
$58.7M
Puts
$47.8M
Net Calls
+$10.9M
Net Calls Change
+$60.3M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$80.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$69.1M |
| 3 |
Millennium Management
New York
|
+$57.1M |
| 4 |
SC
Samlyn Capital
New York
|
+$44.2M |
| 5 |
ACM
Atika Capital Management
New York
|
+$31M |
Top Sellers
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$81.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$75.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$71.6M |
| 4 |
AC
Armistice Capital
New York
|
-$63.2M |
| 5 |
HM
HealthCor Management
New York
|
-$52.9M |
